BBS2 and retinal degeneration: Preclinical evidence supports these findings by showing how CRISPR/Cas9 disruption of the BBS modifier gene Ccdc28b in mice prevented retinal degeneration and obesity but unexpectedly produced autism-like behaviors, emphasizing the complexity of gene–gene interactions in ciliopathies and the value of genome editing for uncovering subtle phenotypic effects [66].